Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival lignocaine versus topical amethocaine pledget for pain during intravitreal anti-VEGF injections
ACTRN12617000182392Phase 4Completed
- Sponsor
- Flinders University
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in retinal diseases comparing Initial subconjunctival lignocaine with Initial topical amethocaine pledget (2 arms). Primary endpoints: Pain score at 5 minutes after intravitreal injection and Pain score at 24 hours after intravitreal injection. Started Apr 2015; status: completed.
02
Drugs
lidocainetetracaine
03
Conditions
retinal diseases
Beyond the preview
Go deeper on ACTRN12617000182392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000182392.